Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1976 Dec;31(6):720–723. doi: 10.1136/thx.31.6.720

Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients.

S J Williams, J P Hartley, J D Graham
PMCID: PMC470501  PMID: 797044

Abstract

Ten volunteer inpatient asthmatics in a steady state were given a single inhalation of an aerosol (63 mul) delivered in random order, on each of three consecutive days, in the laboratory of a respiratory unit. Before, and for one hour after treatment the pulse, blood pressure (lying and standing), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), peak flow rate (PFR), and self-rating mood scales (SRMS) were recorded. Treatments were placebo-ethanol only; delta1-tetrahydrocannabinol (THC) 200 mug in ethanol; or salbutamol 100 mug (Ventolin inhaler), administered double blind. Salbutamol and THC significantly improved ventilatory function. Maximal bronchodilatation was achieved more rapidly with salbutamol, but at 1 hour both drugs were equally effective. No cardiovascular or mood disturbance was detected, and plasma total cannabinoids at 15 minutes were undectable by radioimmunoassay. The mode of action of THC differs from that of sympathomimetic drugs, and it or a derivative may make a suitable adjuvant in the treatment of selected asthmatics.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davies B. H., Radcliffe S., Seaton A., Graham J. D. A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction. Thorax. 1975 Feb;30(1):80–85. doi: 10.1136/thx.30.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. MCNAIR D. M., LORR M. AN ANALYSIS OF MOOD IN NEUROTICS. J Abnorm Psychol. 1964 Dec;69:620–627. doi: 10.1037/h0040902. [DOI] [PubMed] [Google Scholar]
  3. Olsen J. L., Lodge J. W., Shapiro B. J., Tashkin D. P. An inhalation aerosol of delta9-tetrahydrocannabinol. J Pharm Pharmacol. 1976 Jan;28(1):86–86. doi: 10.1111/j.2042-7158.1976.tb04036.x. [DOI] [PubMed] [Google Scholar]
  4. Orehek J., Gayrard P., Grimaud C., Charpin J. Effect of maximal respiratory manoeuvres on bronchial sensitivity of asthmatic patients as compared to normal people. Br Med J. 1975 Jan 18;1(5950):123–125. doi: 10.1136/bmj.1.5950.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. SANERKIN N. G., EVANS D. M. THE SPUTUM IN BRONCHIAL ASTHMA: PATHOGNOMONIC PATTERNS. J Pathol Bacteriol. 1965 Apr;89:535–541. [PubMed] [Google Scholar]
  6. Tashkin D. P., Shapiro B. J., Frank I. M. Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis. 1974 Apr;109(4):420–428. doi: 10.1164/arrd.1974.109.4.420. [DOI] [PubMed] [Google Scholar]
  7. Tashkin D. P., Shapiro B. J., Frank I. M. Acute pulmonary physiologic effects of smoked marijuana and oral 9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973 Aug 16;289(7):336–341. doi: 10.1056/NEJM197308162890702. [DOI] [PubMed] [Google Scholar]
  8. Tashkin D. P., Shapiro B. J., Lee Y. E., Harper C. E. Effects of smoked marijuana in experimentally induced asthma. Am Rev Respir Dis. 1975 Sep;112(3):377–386. doi: 10.1164/arrd.1975.112.3.377. [DOI] [PubMed] [Google Scholar]
  9. Teale J. D., Forman E. J., King L. J., Piall E. M., Marks V. The development of a radioimmunoassay for cannabinoids in blood and urine. J Pharm Pharmacol. 1975 Jul;27(7):465–472. doi: 10.1111/j.2042-7158.1975.tb09486.x. [DOI] [PubMed] [Google Scholar]
  10. Vachon L., FitzGerald M. X., Solliday N. H., Gould I. A., Gaensler E. A. Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med. 1973 May 10;288(19):985–989. doi: 10.1056/NEJM197305102881902. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES